Mercurial > repos > miller-lab > genome_diversity
comparison tool-data/gd.pathways.txt.sample @ 14:8ae67e9fb6ff
Uploaded Miller Lab Devshed version a51c894f5bed again [possible toolshed.g2 bug]
| author | miller-lab |
|---|---|
| date | Fri, 28 Sep 2012 11:35:56 -0400 |
| parents | 2c498d40ecde |
| children |
comparison
equal
deleted
inserted
replaced
| 13:fdb4240fb565 | 14:8ae67e9fb6ff |
|---|---|
| 1 hg19 hsa00010 hsa00010 - Glycolysis/ Gluconeogenesis | |
| 2 hg19 hsa00020 hsa00020 - Citratecycle (TCA cycle) | |
| 3 hg19 hsa00030 hsa00030 - Pentosephosphate pathway | |
| 4 hg19 hsa00040 hsa00040 - Pentoseand glucuronate interconversions | |
| 5 hg19 hsa00051 hsa00051 - Fructoseand mannose metabolism | |
| 6 hg19 hsa00052 hsa00052 - Galactosemetabolism | |
| 7 hg19 hsa00053 hsa00053 - Ascorbateand aldarate metabolism | |
| 8 hg19 hsa00061 hsa00061 - Fattyacid biosynthesis | |
| 9 hg19 hsa00062 hsa00062 - Fattyacid elongation | |
| 10 hg19 hsa00071 hsa00071 - Fattyacid metabolism | |
| 11 hg19 hsa00072 hsa00072 - Synthesisand degradation of ketone bodies | |
| 12 hg19 hsa00100 hsa00100 - Steroidbiosynthesis | |
| 13 hg19 hsa00120 hsa00120 - Primarybile acid biosynthesis | |
| 14 hg19 hsa00130 hsa00130 - Ubiquinoneand other terpenoid-quinone biosynthesis | |
| 15 hg19 hsa00140 hsa00140 - Steroidhormone biosynthesis | |
| 16 hg19 hsa00190 hsa00190 - Oxidativephosphorylation | |
| 17 hg19 hsa00230 hsa00230 - Purinemetabolism | |
| 18 hg19 hsa00232 hsa00232 - Caffeinemetabolism | |
| 19 hg19 hsa00240 hsa00240 - Pyrimidinemetabolism | |
| 20 hg19 hsa00250 hsa00250 - Alanine,aspartate and glutamate metabolism | |
| 21 hg19 hsa00260 hsa00260 - Glycine,serine and threonine metabolism | |
| 22 hg19 hsa00270 hsa00270 - Cysteineand methionine metabolism | |
| 23 hg19 hsa00280 hsa00280 - Valine,leucine and isoleucine degradation | |
| 24 hg19 hsa00290 hsa00290 - Valine,leucine and isoleucine biosynthesis | |
| 25 hg19 hsa00300 hsa00300 - Lysinebiosynthesis | |
| 26 hg19 hsa00310 hsa00310 - Lysinedegradation | |
| 27 hg19 hsa00330 hsa00330 - Arginineand proline metabolism | |
| 28 hg19 hsa00340 hsa00340 - Histidinemetabolism | |
| 29 hg19 hsa00350 hsa00350 - Tyrosinemetabolism | |
| 30 hg19 hsa00360 hsa00360 - Phenylalaninemetabolism | |
| 31 hg19 hsa00380 hsa00380 - Tryptophanmetabolism | |
| 32 hg19 hsa00400 hsa00400 - Phenylalanine,tyrosine and tryptophan biosynthesis | |
| 33 hg19 hsa00410 hsa00410 - beta-Alaninemetabolism | |
| 34 hg19 hsa00430 hsa00430 - Taurineand hypotaurine metabolism | |
| 35 hg19 hsa00450 hsa00450 - Selenocompoundmetabolism | |
| 36 hg19 hsa00460 hsa00460 - Cyanoaminoacid metabolism | |
| 37 hg19 hsa00480 hsa00480 - Glutathionemetabolism | |
| 38 hg19 hsa00500 hsa00500 - Starchand sucrose metabolism | |
| 39 hg19 hsa00510 hsa00510 - N-Glycanbiosynthesis | |
| 40 hg19 hsa00511 hsa00511 - Otherglycan degradation | |
| 41 hg19 hsa00512 hsa00512 - Mucintype O-Glycan biosynthesis | |
| 42 hg19 hsa00514 hsa00514 - Othertypes of O-glycan biosynthesis | |
| 43 hg19 hsa00520 hsa00520 - Aminosugar and nucleotide sugar metabolism | |
| 44 hg19 hsa00524 hsa00524 - Butirosinand neomycin biosynthesis | |
| 45 hg19 hsa00531 hsa00531 - Glycosaminoglycandegradation | |
| 46 hg19 hsa00532 hsa00532 - Glycosaminoglycanbiosynthesis - chondroitin sulfate | |
| 47 hg19 hsa00533 hsa00533 - Glycosaminoglycanbiosynthesis - keratan sulfate | |
| 48 hg19 hsa00534 hsa00534 - Glycosaminoglycanbiosynthesis - heparan sulfate | |
| 49 hg19 hsa00561 hsa00561 - Glycerolipidmetabolism | |
| 50 hg19 hsa00562 hsa00562 - Inositolphosphate metabolism | |
| 51 hg19 hsa00563 hsa00563 - Glycosylphosphatidylinositol(GPI)-anchorbiosynthesis | |
| 52 hg19 hsa00564 hsa00564 - Glycerophospholipidmetabolism | |
| 53 hg19 hsa00565 hsa00565 - Etherlipid metabolism | |
| 54 hg19 hsa00590 hsa00590 - Arachidonicacid metabolism | |
| 55 hg19 hsa00591 hsa00591 - Linoleicacid metabolism | |
| 56 hg19 hsa00592 hsa00592 - alpha-Linolenicacid metabolism | |
| 57 hg19 hsa00600 hsa00600 - Sphingolipidmetabolism | |
| 58 hg19 hsa00601 hsa00601 - Glycosphingolipidbiosynthesis - lacto and neolacto series | |
| 59 hg19 hsa00603 hsa00603 - Glycosphingolipidbiosynthesis - globo series | |
| 60 hg19 hsa00604 hsa00604 - Glycosphingolipidbiosynthesis - ganglio series | |
| 61 hg19 hsa00620 hsa00620 - Pyruvatemetabolism | |
| 62 hg19 hsa00630 hsa00630 - Glyoxylateand dicarboxylate metabolism | |
| 63 hg19 hsa00640 hsa00640 - Propanoatemetabolism | |
| 64 hg19 hsa00650 hsa00650 - Butanoatemetabolism | |
| 65 hg19 hsa00670 hsa00670 - Onecarbon pool by folate | |
| 66 hg19 hsa00730 hsa00730 - Thiaminemetabolism | |
| 67 hg19 hsa00740 hsa00740 - Riboflavinmetabolism | |
| 68 hg19 hsa00750 hsa00750 - VitaminB6 metabolism | |
| 69 hg19 hsa00760 hsa00760 - Nicotinateand nicotinamide metabolism | |
| 70 hg19 hsa00770 hsa00770 - Pantothenateand CoA biosynthesis | |
| 71 hg19 hsa00780 hsa00780 - Biotinmetabolism | |
| 72 hg19 hsa00785 hsa00785 - Lipoicacid metabolism | |
| 73 hg19 hsa00790 hsa00790 - Folatebiosynthesis | |
| 74 hg19 hsa00830 hsa00830 - Retinolmetabolism | |
| 75 hg19 hsa00860 hsa00860 - Porphyrinand chlorophyll metabolism | |
| 76 hg19 hsa00900 hsa00900 - Terpenoidbackbone biosynthesis | |
| 77 hg19 hsa00910 hsa00910 - Nitrogenmetabolism | |
| 78 hg19 hsa00920 hsa00920 - Sulfurmetabolism | |
| 79 hg19 hsa00970 hsa00970 - Aminoacyl-tRNAbiosynthesis | |
| 80 hg19 hsa00980 hsa00980 - Metabolismof xenobiotics by cytochrome P450 | |
| 81 hg19 hsa00982 hsa00982 - Drugmetabolism - cytochrome P450 | |
| 82 hg19 hsa00983 hsa00983 - Drugmetabolism - other enzymes | |
| 83 hg19 hsa01040 hsa01040 - Biosynthesisof unsaturated fatty acids | |
| 84 hg19 hsa01100 hsa01100 - Metabolicpathways | |
| 85 hg19 hsa02010 hsa02010 - ABCtransporters | |
| 86 hg19 hsa03008 hsa03008 - Ribosomebiogenesis in eukaryotes | |
| 87 hg19 hsa03010 hsa03010 - Ribosome | |
| 88 hg19 hsa03013 hsa03013 - RNAtransport | |
| 89 hg19 hsa03015 hsa03015 - mRNAsurveillance pathway | |
| 90 hg19 hsa03018 hsa03018 - RNAdegradation | |
| 91 hg19 hsa03020 hsa03020 - RNApolymerase | |
| 92 hg19 hsa03022 hsa03022 - Basaltranscription factors | |
| 93 hg19 hsa03030 hsa03030 - DNAreplication | |
| 94 hg19 hsa03040 hsa03040 - Spliceosome | |
| 95 hg19 hsa03050 hsa03050 - Proteasome | |
| 96 hg19 hsa03060 hsa03060 - Proteinexport | |
| 97 hg19 hsa03320 hsa03320 - PPARsignaling pathway | |
| 98 hg19 hsa03410 hsa03410 - Baseexcision repair | |
| 99 hg19 hsa03420 hsa03420 - Nucleotideexcision repair | |
| 100 hg19 hsa03430 hsa03430 - Mismatchrepair | |
| 101 hg19 hsa03440 hsa03440 - Homologousrecombination | |
| 102 hg19 hsa03450 hsa03450 - Non-homologousend-joining | |
| 103 hg19 hsa03460 hsa03460 - Fanconianemia pathway | |
| 104 hg19 hsa04010 hsa04010 - MAPKsignaling pathway | |
| 105 hg19 hsa04012 hsa04012 - ErbBsignaling pathway | |
| 106 hg19 hsa04020 hsa04020 - Calciumsignaling pathway | |
| 107 hg19 hsa04060 hsa04060 - Cytokine-cytokinereceptor interaction | |
| 108 hg19 hsa04062 hsa04062 - Chemokinesignaling pathway | |
| 109 hg19 hsa04070 hsa04070 - Phosphatidylinositolsignaling system | |
| 110 hg19 hsa04080 hsa04080 - Neuroactiveligand-receptor interaction | |
| 111 hg19 hsa04110 hsa04110 - Cellcycle | |
| 112 hg19 hsa04114 hsa04114 - Oocytemeiosis | |
| 113 hg19 hsa04115 hsa04115 - p53signaling pathway | |
| 114 hg19 hsa04120 hsa04120 - Ubiquitinmediated proteolysis | |
| 115 hg19 hsa04122 hsa04122 - Sulfurrelay system | |
| 116 hg19 hsa04130 hsa04130 - SNAREinteractions in vesicular transport | |
| 117 hg19 hsa04140 hsa04140 - Regulationof autophagy | |
| 118 hg19 hsa04141 hsa04141 - Proteinprocessing in endoplasmic reticulum | |
| 119 hg19 hsa04142 hsa04142 - Lysosome | |
| 120 hg19 hsa04144 hsa04144 - Endocytosis | |
| 121 hg19 hsa04145 hsa04145 - Phagosome | |
| 122 hg19 hsa04146 hsa04146 - Peroxisome | |
| 123 hg19 hsa04150 hsa04150 - mTORsignaling pathway | |
| 124 hg19 hsa04210 hsa04210 - Apoptosis | |
| 125 hg19 hsa04260 hsa04260 - Cardiacmuscle contraction | |
| 126 hg19 hsa04270 hsa04270 - Vascularsmooth muscle contraction | |
| 127 hg19 hsa04310 hsa04310 - Wntsignaling pathway | |
| 128 hg19 hsa04320 hsa04320 - Dorso-ventralaxis formation | |
| 129 hg19 hsa04330 hsa04330 - Notchsignaling pathway | |
| 130 hg19 hsa04340 hsa04340 - Hedgehogsignaling pathway | |
| 131 hg19 hsa04350 hsa04350 - TGF-betasignaling pathway | |
| 132 hg19 hsa04360 hsa04360 - Axonguidance | |
| 133 hg19 hsa04370 hsa04370 - VEGFsignaling pathway | |
| 134 hg19 hsa04380 hsa04380 - Osteoclastdifferentiation | |
| 135 hg19 hsa04510 hsa04510 - Focaladhesion | |
| 136 hg19 hsa04512 hsa04512 - ECM-receptorinteraction | |
| 137 hg19 hsa04514 hsa04514 - Celladhesion molecules (CAMs) | |
| 138 hg19 hsa04520 hsa04520 - Adherensjunction | |
| 139 hg19 hsa04530 hsa04530 - Tightjunction | |
| 140 hg19 hsa04540 hsa04540 - Gapjunction | |
| 141 hg19 hsa04610 hsa04610 - Complementand coagulation cascades | |
| 142 hg19 hsa04612 hsa04612 - Antigenprocessing and presentation | |
| 143 hg19 hsa04614 hsa04614 - Renin-angiotensinsystem | |
| 144 hg19 hsa04620 hsa04620 - Toll-likereceptor signaling pathway | |
| 145 hg19 hsa04621 hsa04621 - NOD-likereceptor signaling pathway | |
| 146 hg19 hsa04622 hsa04622 - RIG-I-likereceptor signaling pathway | |
| 147 hg19 hsa04623 hsa04623 - CytosolicDNA-sensing pathway | |
| 148 hg19 hsa04630 hsa04630 - Jak-STATsignaling pathway | |
| 149 hg19 hsa04640 hsa04640 - Hematopoieticcell lineage | |
| 150 hg19 hsa04650 hsa04650 - Naturalkiller cell mediated cytotoxicity | |
| 151 hg19 hsa04660 hsa04660 - Tcell receptor signaling pathway | |
| 152 hg19 hsa04662 hsa04662 - Bcell receptor signaling pathway | |
| 153 hg19 hsa04664 hsa04664 - Fcepsilon RI signaling pathway | |
| 154 hg19 hsa04666 hsa04666 - Fcgamma R-mediated phagocytosis | |
| 155 hg19 hsa04670 hsa04670 - Leukocytetransendothelial migration | |
| 156 hg19 hsa04672 hsa04672 - Intestinalimmune network for IgA production | |
| 157 hg19 hsa04710 hsa04710 - Circadianrhythm - mammal | |
| 158 hg19 hsa04720 hsa04720 - Long-termpotentiation | |
| 159 hg19 hsa04721 hsa04721 - Synapticvesicle cycle | |
| 160 hg19 hsa04722 hsa04722 - Neurotrophinsignaling pathway | |
| 161 hg19 hsa04724 hsa04724 - Glutamatergicsynapse | |
| 162 hg19 hsa04725 hsa04725 - Cholinergicsynapse | |
| 163 hg19 hsa04727 hsa04727 - GABAergicsynapse | |
| 164 hg19 hsa04728 hsa04728 - Dopaminergicsynapse | |
| 165 hg19 hsa04730 hsa04730 - Long-termdepression | |
| 166 hg19 hsa04740 hsa04740 - Olfactorytransduction | |
| 167 hg19 hsa04742 hsa04742 - Tastetransduction | |
| 168 hg19 hsa04744 hsa04744 - Phototransduction | |
| 169 hg19 hsa04810 hsa04810 - Regulationof actin cytoskeleton | |
| 170 hg19 hsa04910 hsa04910 - Insulinsignaling pathway | |
| 171 hg19 hsa04912 hsa04912 - GnRHsignaling pathway | |
| 172 hg19 hsa04914 hsa04914 - Progesterone-mediatedoocyte maturation | |
| 173 hg19 hsa04916 hsa04916 - Melanogenesis | |
| 174 hg19 hsa04920 hsa04920 - Adipocytokinesignaling pathway | |
| 175 hg19 hsa04930 hsa04930 - TypeII diabetes mellitus | |
| 176 hg19 hsa04940 hsa04940 - TypeI diabetes mellitus | |
| 177 hg19 hsa04950 hsa04950 - Maturityonset diabetes of the young | |
| 178 hg19 hsa04960 hsa04960 - Aldosterone-regulatedsodium reabsorption | |
| 179 hg19 hsa04961 hsa04961 - Endocrineand other factor-regulated calcium reabsorption | |
| 180 hg19 hsa04962 hsa04962 - Vasopressin-regulatedwater reabsorption | |
| 181 hg19 hsa04964 hsa04964 - Proximaltubule bicarbonate reclamation | |
| 182 hg19 hsa04966 hsa04966 - Collectingduct acid secretion | |
| 183 hg19 hsa04970 hsa04970 - Salivarysecretion | |
| 184 hg19 hsa04971 hsa04971 - Gastricacid secretion | |
| 185 hg19 hsa04972 hsa04972 - Pancreaticsecretion | |
| 186 hg19 hsa04973 hsa04973 - Carbohydratedigestion and absorption | |
| 187 hg19 hsa04974 hsa04974 - Proteindigestion and absorption | |
| 188 hg19 hsa04975 hsa04975 - Fatdigestion and absorption | |
| 189 hg19 hsa04976 hsa04976 - Bilesecretion | |
| 190 hg19 hsa04977 hsa04977 - Vitamindigestion and absorption | |
| 191 hg19 hsa04978 hsa04978 - Mineralabsorption | |
| 192 hg19 hsa05010 hsa05010 - Alzheimer'sdisease | |
| 193 hg19 hsa05012 hsa05012 - Parkinson'sdisease | |
| 194 hg19 hsa05014 hsa05014 - Amyotrophiclateral sclerosis (ALS) | |
| 195 hg19 hsa05016 hsa05016 - Huntington'sdisease | |
| 196 hg19 hsa05020 hsa05020 - Priondiseases | |
| 197 hg19 hsa05100 hsa05100 - Bacterialinvasion of epithelial cells | |
| 198 hg19 hsa05132 hsa05132 - Salmonellainfection | |
| 199 hg19 hsa05133 hsa05133 - Pertussis | |
| 200 hg19 hsa05134 hsa05134 - Legionellosis | |
| 201 hg19 hsa05140 hsa05140 - Leishmaniasis | |
| 202 hg19 hsa05142 hsa05142 - Chagasdisease (American trypanosomiasis) | |
| 203 hg19 hsa05143 hsa05143 - Africantrypanosomiasis | |
| 204 hg19 hsa05144 hsa05144 - Malaria | |
| 205 hg19 hsa05145 hsa05145 - Toxoplasmosis | |
| 206 hg19 hsa05146 hsa05146 - Amoebiasis | |
| 207 hg19 hsa05150 hsa05150 - Staphylococcusaureus infection | |
| 208 hg19 hsa05152 hsa05152 - Tuberculosis | |
| 209 hg19 hsa05160 hsa05160 - HepatitisC | |
| 210 hg19 hsa05162 hsa05162 - Measles | |
| 211 hg19 hsa05164 hsa05164 - InfluenzaA | |
| 212 hg19 hsa05166 hsa05166 - HTLV-Iinfection | |
| 213 hg19 hsa05168 hsa05168 - Herpessimplex infection | |
| 214 hg19 hsa05200 hsa05200 - Pathwaysin cancer | |
| 215 hg19 hsa05202 hsa05202 - Transcriptionalmisregulation in cancers | |
| 216 hg19 hsa05210 hsa05210 - Colorectalcancer | |
| 217 hg19 hsa05211 hsa05211 - Renalcell carcinoma | |
| 218 hg19 hsa05212 hsa05212 - Pancreaticcancer | |
| 219 hg19 hsa05213 hsa05213 - Endometrialcancer | |
| 220 hg19 hsa05214 hsa05214 - Glioma | |
| 221 hg19 hsa05215 hsa05215 - Prostatecancer | |
| 222 hg19 hsa05216 hsa05216 - Thyroidcancer | |
| 223 hg19 hsa05217 hsa05217 - Basalcell carcinoma | |
| 224 hg19 hsa05218 hsa05218 - Melanoma | |
| 225 hg19 hsa05219 hsa05219 - Bladdercancer | |
| 226 hg19 hsa05220 hsa05220 - Chronicmyeloid leukemia | |
| 227 hg19 hsa05221 hsa05221 - Acutemyeloid leukemia | |
| 228 hg19 hsa05222 hsa05222 - Smallcell lung cancer | |
| 229 hg19 hsa05223 hsa05223 - Non-smallcell lung cancer | |
| 230 hg19 hsa05310 hsa05310 - Asthma | |
| 231 hg19 hsa05320 hsa05320 - Autoimmunethyroid disease | |
| 232 hg19 hsa05322 hsa05322 - Systemiclupus erythematosus | |
| 233 hg19 hsa05323 hsa05323 - Rheumatoidarthritis | |
| 234 hg19 hsa05330 hsa05330 - Allograftrejection | |
| 235 hg19 hsa05332 hsa05332 - Graft-versus-hostdisease | |
| 236 hg19 hsa05340 hsa05340 - Primaryimmunodeficiency | |
| 237 hg19 hsa05410 hsa05410 - Hypertrophiccardiomyopathy (HCM) | |
| 238 hg19 hsa05412 hsa05412 - Arrhythmogenicright ventricular cardiomyopathy (ARVC) | |
| 239 hg19 hsa05414 hsa05414 - Dilatedcardiomyopathy | |
| 240 hg19 hsa05416 hsa05416 - Viralmyocarditis | |
| 241 canFam2 cfa00010 cfa00010 - Glycolysis/ Gluconeogenesis | |
| 242 canFam2 cfa00020 cfa00020 - Citratecycle (TCA cycle) | |
| 243 canFam2 cfa00030 cfa00030 - Pentosephosphate pathway | |
| 244 canFam2 cfa00040 cfa00040 - Pentoseand glucuronate interconversions | |
| 245 canFam2 cfa00051 cfa00051 - Fructoseand mannose metabolism | |
| 246 canFam2 cfa00052 cfa00052 - Galactosemetabolism | |
| 247 canFam2 cfa00053 cfa00053 - Ascorbateand aldarate metabolism | |
| 248 canFam2 cfa00061 cfa00061 - Fattyacid biosynthesis | |
| 249 canFam2 cfa00062 cfa00062 - Fattyacid elongation in mitochondria | |
| 250 canFam2 cfa00071 cfa00071 - Fattyacid metabolism | |
| 251 canFam2 cfa00072 cfa00072 - Synthesisand degradation of ketone bodies | |
| 252 canFam2 cfa00100 cfa00100 - Steroidbiosynthesis | |
| 253 canFam2 cfa00120 cfa00120 - Primarybile acid biosynthesis | |
| 254 canFam2 cfa00130 cfa00130 - Ubiquinoneand other terpenoid-quinone biosynthesis | |
| 255 canFam2 cfa00140 cfa00140 - Steroidhormone biosynthesis | |
| 256 canFam2 cfa00190 cfa00190 - Oxidativephosphorylation | |
| 257 canFam2 cfa00230 cfa00230 - Purinemetabolism | |
| 258 canFam2 cfa00232 cfa00232 - Caffeinemetabolism | |
| 259 canFam2 cfa00240 cfa00240 - Pyrimidinemetabolism | |
| 260 canFam2 cfa00250 cfa00250 - Alanine,aspartate and glutamate metabolism | |
| 261 canFam2 cfa00260 cfa00260 - Glycine,serine and threonine metabolism | |
| 262 canFam2 cfa00270 cfa00270 - Cysteineand methionine metabolism | |
| 263 canFam2 cfa00280 cfa00280 - Valine,leucine and isoleucine degradation | |
| 264 canFam2 cfa00290 cfa00290 - Valine,leucine and isoleucine biosynthesis | |
| 265 canFam2 cfa00300 cfa00300 - Lysinebiosynthesis | |
| 266 canFam2 cfa00310 cfa00310 - Lysinedegradation | |
| 267 canFam2 cfa00330 cfa00330 - Arginineand proline metabolism | |
| 268 canFam2 cfa00340 cfa00340 - Histidinemetabolism | |
| 269 canFam2 cfa00350 cfa00350 - Tyrosinemetabolism | |
| 270 canFam2 cfa00360 cfa00360 - Phenylalaninemetabolism | |
| 271 canFam2 cfa00380 cfa00380 - Tryptophanmetabolism | |
| 272 canFam2 cfa00400 cfa00400 - Phenylalanine,tyrosine and tryptophan biosynthesis | |
| 273 canFam2 cfa00410 cfa00410 - beta-Alaninemetabolism | |
| 274 canFam2 cfa00430 cfa00430 - Taurineand hypotaurine metabolism | |
| 275 canFam2 cfa00450 cfa00450 - Selenocompoundmetabolism | |
| 276 canFam2 cfa00460 cfa00460 - Cyanoaminoacid metabolism | |
| 277 canFam2 cfa00472 cfa00472 - D-Arginineand D-ornithine metabolism | |
| 278 canFam2 cfa00480 cfa00480 - Glutathionemetabolism | |
| 279 canFam2 cfa00500 cfa00500 - Starchand sucrose metabolism | |
| 280 canFam2 cfa00510 cfa00510 - N-Glycanbiosynthesis | |
| 281 canFam2 cfa00511 cfa00511 - Otherglycan degradation | |
| 282 canFam2 cfa00512 cfa00512 - Mucintype O-Glycan biosynthesis | |
| 283 canFam2 cfa00514 cfa00514 - Othertypes of O-glycan biosynthesis | |
| 284 canFam2 cfa00520 cfa00520 - Aminosugar and nucleotide sugar metabolism | |
| 285 canFam2 cfa00531 cfa00531 - Glycosaminoglycandegradation | |
| 286 canFam2 cfa00532 cfa00532 - Glycosaminoglycanbiosynthesis - chondroitin sulfate | |
| 287 canFam2 cfa00533 cfa00533 - Glycosaminoglycanbiosynthesis - keratan sulfate | |
| 288 canFam2 cfa00534 cfa00534 - Glycosaminoglycanbiosynthesis - heparan sulfate | |
| 289 canFam2 cfa00561 cfa00561 - Glycerolipidmetabolism | |
| 290 canFam2 cfa00562 cfa00562 - Inositolphosphate metabolism | |
| 291 canFam2 cfa00563 cfa00563 - Glycosylphosphatidylinositol(GPI)-anchorbiosynthesis | |
| 292 canFam2 cfa00564 cfa00564 - Glycerophospholipidmetabolism | |
| 293 canFam2 cfa00565 cfa00565 - Etherlipid metabolism | |
| 294 canFam2 cfa00590 cfa00590 - Arachidonicacid metabolism | |
| 295 canFam2 cfa00591 cfa00591 - Linoleicacid metabolism | |
| 296 canFam2 cfa00592 cfa00592 - alpha-Linolenicacid metabolism | |
| 297 canFam2 cfa00600 cfa00600 - Sphingolipidmetabolism | |
| 298 canFam2 cfa00601 cfa00601 - Glycosphingolipidbiosynthesis - lacto and neolacto series | |
| 299 canFam2 cfa00603 cfa00603 - Glycosphingolipidbiosynthesis - globo series | |
| 300 canFam2 cfa00604 cfa00604 - Glycosphingolipidbiosynthesis - ganglio series | |
| 301 canFam2 cfa00620 cfa00620 - Pyruvatemetabolism | |
| 302 canFam2 cfa00630 cfa00630 - Glyoxylateand dicarboxylate metabolism | |
| 303 canFam2 cfa00640 cfa00640 - Propanoatemetabolism | |
| 304 canFam2 cfa00650 cfa00650 - Butanoatemetabolism | |
| 305 canFam2 cfa00670 cfa00670 - Onecarbon pool by folate | |
| 306 canFam2 cfa00730 cfa00730 - Thiaminemetabolism | |
| 307 canFam2 cfa00740 cfa00740 - Riboflavinmetabolism | |
| 308 canFam2 cfa00750 cfa00750 - VitaminB6 metabolism | |
| 309 canFam2 cfa00760 cfa00760 - Nicotinateand nicotinamide metabolism | |
| 310 canFam2 cfa00770 cfa00770 - Pantothenateand CoA biosynthesis | |
| 311 canFam2 cfa00780 cfa00780 - Biotinmetabolism | |
| 312 canFam2 cfa00785 cfa00785 - Lipoicacid metabolism | |
| 313 canFam2 cfa00790 cfa00790 - Folatebiosynthesis | |
| 314 canFam2 cfa00830 cfa00830 - Retinolmetabolism | |
| 315 canFam2 cfa00860 cfa00860 - Porphyrinand chlorophyll metabolism | |
| 316 canFam2 cfa00900 cfa00900 - Terpenoidbackbone biosynthesis | |
| 317 canFam2 cfa00910 cfa00910 - Nitrogenmetabolism | |
| 318 canFam2 cfa00920 cfa00920 - Sulfurmetabolism | |
| 319 canFam2 cfa00970 cfa00970 - Aminoacyl-tRNAbiosynthesis | |
| 320 canFam2 cfa00980 cfa00980 - Metabolismof xenobiotics by cytochrome P450 | |
| 321 canFam2 cfa00982 cfa00982 - Drugmetabolism - cytochrome P450 | |
| 322 canFam2 cfa00983 cfa00983 - Drugmetabolism - other enzymes | |
| 323 canFam2 cfa01040 cfa01040 - Biosynthesisof unsaturated fatty acids | |
| 324 canFam2 cfa01100 cfa01100 - Metabolicpathways | |
| 325 canFam2 cfa02010 cfa02010 - ABCtransporters | |
| 326 canFam2 cfa03008 cfa03008 - Ribosomebiogenesis in eukaryotes | |
| 327 canFam2 cfa03010 cfa03010 - Ribosome | |
| 328 canFam2 cfa03013 cfa03013 - RNAtransport | |
| 329 canFam2 cfa03015 cfa03015 - mRNAsurveillance pathway | |
| 330 canFam2 cfa03018 cfa03018 - RNAdegradation | |
| 331 canFam2 cfa03020 cfa03020 - RNApolymerase | |
| 332 canFam2 cfa03022 cfa03022 - Basaltranscription factors | |
| 333 canFam2 cfa03030 cfa03030 - DNAreplication | |
| 334 canFam2 cfa03040 cfa03040 - Spliceosome | |
| 335 canFam2 cfa03050 cfa03050 - Proteasome | |
| 336 canFam2 cfa03060 cfa03060 - Proteinexport | |
| 337 canFam2 cfa03320 cfa03320 - PPARsignaling pathway | |
| 338 canFam2 cfa03410 cfa03410 - Baseexcision repair | |
| 339 canFam2 cfa03420 cfa03420 - Nucleotideexcision repair | |
| 340 canFam2 cfa03430 cfa03430 - Mismatchrepair | |
| 341 canFam2 cfa03440 cfa03440 - Homologousrecombination | |
| 342 canFam2 cfa03450 cfa03450 - Non-homologousend-joining | |
| 343 canFam2 cfa03460 cfa03460 - Fanconianemia pathway | |
| 344 canFam2 cfa04010 cfa04010 - MAPKsignaling pathway | |
| 345 canFam2 cfa04012 cfa04012 - ErbBsignaling pathway | |
| 346 canFam2 cfa04020 cfa04020 - Calciumsignaling pathway | |
| 347 canFam2 cfa04060 cfa04060 - Cytokine-cytokinereceptor interaction | |
| 348 canFam2 cfa04062 cfa04062 - Chemokinesignaling pathway | |
| 349 canFam2 cfa04070 cfa04070 - Phosphatidylinositolsignaling system | |
| 350 canFam2 cfa04080 cfa04080 - Neuroactiveligand-receptor interaction | |
| 351 canFam2 cfa04110 cfa04110 - Cellcycle | |
| 352 canFam2 cfa04114 cfa04114 - Oocytemeiosis | |
| 353 canFam2 cfa04115 cfa04115 - p53signaling pathway | |
| 354 canFam2 cfa04120 cfa04120 - Ubiquitinmediated proteolysis | |
| 355 canFam2 cfa04122 cfa04122 - Sulfurrelay system | |
| 356 canFam2 cfa04130 cfa04130 - SNAREinteractions in vesicular transport | |
| 357 canFam2 cfa04140 cfa04140 - Regulationof autophagy | |
| 358 canFam2 cfa04141 cfa04141 - Proteinprocessing in endoplasmic reticulum | |
| 359 canFam2 cfa04142 cfa04142 - Lysosome | |
| 360 canFam2 cfa04144 cfa04144 - Endocytosis | |
| 361 canFam2 cfa04145 cfa04145 - Phagosome | |
| 362 canFam2 cfa04146 cfa04146 - Peroxisome | |
| 363 canFam2 cfa04150 cfa04150 - mTORsignaling pathway | |
| 364 canFam2 cfa04210 cfa04210 - Apoptosis | |
| 365 canFam2 cfa04260 cfa04260 - Cardiacmuscle contraction | |
| 366 canFam2 cfa04270 cfa04270 - Vascularsmooth muscle contraction | |
| 367 canFam2 cfa04310 cfa04310 - Wntsignaling pathway | |
| 368 canFam2 cfa04320 cfa04320 - Dorso-ventralaxis formation | |
| 369 canFam2 cfa04330 cfa04330 - Notchsignaling pathway | |
| 370 canFam2 cfa04340 cfa04340 - Hedgehogsignaling pathway | |
| 371 canFam2 cfa04350 cfa04350 - TGF-betasignaling pathway | |
| 372 canFam2 cfa04360 cfa04360 - Axonguidance | |
| 373 canFam2 cfa04370 cfa04370 - VEGFsignaling pathway | |
| 374 canFam2 cfa04380 cfa04380 - Osteoclastdifferentiation | |
| 375 canFam2 cfa04510 cfa04510 - Focaladhesion | |
| 376 canFam2 cfa04512 cfa04512 - ECM-receptorinteraction | |
| 377 canFam2 cfa04514 cfa04514 - Celladhesion molecules (CAMs) | |
| 378 canFam2 cfa04520 cfa04520 - Adherensjunction | |
| 379 canFam2 cfa04530 cfa04530 - Tightjunction | |
| 380 canFam2 cfa04540 cfa04540 - Gapjunction | |
| 381 canFam2 cfa04610 cfa04610 - Complementand coagulation cascades | |
| 382 canFam2 cfa04612 cfa04612 - Antigenprocessing and presentation | |
| 383 canFam2 cfa04614 cfa04614 - Renin-angiotensinsystem | |
| 384 canFam2 cfa04620 cfa04620 - Toll-likereceptor signaling pathway | |
| 385 canFam2 cfa04621 cfa04621 - NOD-likereceptor signaling pathway | |
| 386 canFam2 cfa04622 cfa04622 - RIG-I-likereceptor signaling pathway | |
| 387 canFam2 cfa04623 cfa04623 - CytosolicDNA-sensing pathway | |
| 388 canFam2 cfa04630 cfa04630 - Jak-STATsignaling pathway | |
| 389 canFam2 cfa04640 cfa04640 - Hematopoieticcell lineage | |
| 390 canFam2 cfa04650 cfa04650 - Naturalkiller cell mediated cytotoxicity | |
| 391 canFam2 cfa04660 cfa04660 - Tcell receptor signaling pathway | |
| 392 canFam2 cfa04662 cfa04662 - Bcell receptor signaling pathway | |
| 393 canFam2 cfa04664 cfa04664 - Fcepsilon RI signaling pathway | |
| 394 canFam2 cfa04666 cfa04666 - Fcgamma R-mediated phagocytosis | |
| 395 canFam2 cfa04670 cfa04670 - Leukocytetransendothelial migration | |
| 396 canFam2 cfa04672 cfa04672 - Intestinalimmune network for IgA production | |
| 397 canFam2 cfa04710 cfa04710 - Circadianrhythm - mammal | |
| 398 canFam2 cfa04720 cfa04720 - Long-termpotentiation | |
| 399 canFam2 cfa04721 cfa04721 - Synapticvesicle cycle | |
| 400 canFam2 cfa04722 cfa04722 - Neurotrophinsignaling pathway | |
| 401 canFam2 cfa04724 cfa04724 - Glutamatergicsynapse | |
| 402 canFam2 cfa04725 cfa04725 - Cholinergicsynapse | |
| 403 canFam2 cfa04727 cfa04727 - GABAergicsynapse | |
| 404 canFam2 cfa04728 cfa04728 - Dopaminergicsynapse | |
| 405 canFam2 cfa04730 cfa04730 - Long-termdepression | |
| 406 canFam2 cfa04740 cfa04740 - Olfactorytransduction | |
| 407 canFam2 cfa04742 cfa04742 - Tastetransduction | |
| 408 canFam2 cfa04744 cfa04744 - Phototransduction | |
| 409 canFam2 cfa04810 cfa04810 - Regulationof actin cytoskeleton | |
| 410 canFam2 cfa04910 cfa04910 - Insulinsignaling pathway | |
| 411 canFam2 cfa04912 cfa04912 - GnRHsignaling pathway | |
| 412 canFam2 cfa04914 cfa04914 - Progesterone-mediatedoocyte maturation | |
| 413 canFam2 cfa04916 cfa04916 - Melanogenesis | |
| 414 canFam2 cfa04920 cfa04920 - Adipocytokinesignaling pathway | |
| 415 canFam2 cfa04930 cfa04930 - TypeII diabetes mellitus | |
| 416 canFam2 cfa04940 cfa04940 - TypeI diabetes mellitus | |
| 417 canFam2 cfa04950 cfa04950 - Maturityonset diabetes of the young | |
| 418 canFam2 cfa04960 cfa04960 - Aldosterone-regulatedsodium reabsorption | |
| 419 canFam2 cfa04961 cfa04961 - Endocrineand other factor-regulated calcium reabsorption | |
| 420 canFam2 cfa04962 cfa04962 - Vasopressin-regulatedwater reabsorption | |
| 421 canFam2 cfa04964 cfa04964 - Proximaltubule bicarbonate reclamation | |
| 422 canFam2 cfa04966 cfa04966 - Collectingduct acid secretion | |
| 423 canFam2 cfa04970 cfa04970 - Salivarysecretion | |
| 424 canFam2 cfa04971 cfa04971 - Gastricacid secretion | |
| 425 canFam2 cfa04972 cfa04972 - Pancreaticsecretion | |
| 426 canFam2 cfa04973 cfa04973 - Carbohydratedigestion and absorption | |
| 427 canFam2 cfa04974 cfa04974 - Proteindigestion and absorption | |
| 428 canFam2 cfa04975 cfa04975 - Fatdigestion and absorption | |
| 429 canFam2 cfa04976 cfa04976 - Bilesecretion | |
| 430 canFam2 cfa04977 cfa04977 - Vitamindigestion and absorption | |
| 431 canFam2 cfa04978 cfa04978 - Mineralabsorption | |
| 432 canFam2 cfa05010 cfa05010 - Alzheimer'sdisease | |
| 433 canFam2 cfa05012 cfa05012 - Parkinson'sdisease | |
| 434 canFam2 cfa05014 cfa05014 - Amyotrophiclateral sclerosis (ALS) | |
| 435 canFam2 cfa05016 cfa05016 - Huntington'sdisease | |
| 436 canFam2 cfa05020 cfa05020 - Priondiseases | |
| 437 canFam2 cfa05100 cfa05100 - Bacterialinvasion of epithelial cells | |
| 438 canFam2 cfa05132 cfa05132 - Salmonellainfection | |
| 439 canFam2 cfa05133 cfa05133 - Pertussis | |
| 440 canFam2 cfa05134 cfa05134 - Legionellosis | |
| 441 canFam2 cfa05140 cfa05140 - Leishmaniasis | |
| 442 canFam2 cfa05142 cfa05142 - Chagasdisease (American trypanosomiasis) | |
| 443 canFam2 cfa05143 cfa05143 - Africantrypanosomiasis | |
| 444 canFam2 cfa05144 cfa05144 - Malaria | |
| 445 canFam2 cfa05145 cfa05145 - Toxoplasmosis | |
| 446 canFam2 cfa05146 cfa05146 - Amoebiasis | |
| 447 canFam2 cfa05150 cfa05150 - Staphylococcusaureus infection | |
| 448 canFam2 cfa05152 cfa05152 - Tuberculosis | |
| 449 canFam2 cfa05160 cfa05160 - HepatitisC | |
| 450 canFam2 cfa05162 cfa05162 - Measles | |
| 451 canFam2 cfa05164 cfa05164 - InfluenzaA | |
| 452 canFam2 cfa05166 cfa05166 - HTLV-Iinfection | |
| 453 canFam2 cfa05168 cfa05168 - Herpessimplex infection | |
| 454 canFam2 cfa05200 cfa05200 - Pathwaysin cancer | |
| 455 canFam2 cfa05210 cfa05210 - Colorectalcancer | |
| 456 canFam2 cfa05211 cfa05211 - Renalcell carcinoma | |
| 457 canFam2 cfa05212 cfa05212 - Pancreaticcancer | |
| 458 canFam2 cfa05213 cfa05213 - Endometrialcancer | |
| 459 canFam2 cfa05214 cfa05214 - Glioma | |
| 460 canFam2 cfa05215 cfa05215 - Prostatecancer | |
| 461 canFam2 cfa05216 cfa05216 - Thyroidcancer | |
| 462 canFam2 cfa05217 cfa05217 - Basalcell carcinoma | |
| 463 canFam2 cfa05218 cfa05218 - Melanoma | |
| 464 canFam2 cfa05219 cfa05219 - Bladdercancer | |
| 465 canFam2 cfa05220 cfa05220 - Chronicmyeloid leukemia | |
| 466 canFam2 cfa05221 cfa05221 - Acutemyeloid leukemia | |
| 467 canFam2 cfa05222 cfa05222 - Smallcell lung cancer | |
| 468 canFam2 cfa05223 cfa05223 - Non-smallcell lung cancer | |
| 469 canFam2 cfa05310 cfa05310 - Asthma | |
| 470 canFam2 cfa05320 cfa05320 - Autoimmunethyroid disease | |
| 471 canFam2 cfa05322 cfa05322 - Systemiclupus erythematosus | |
| 472 canFam2 cfa05323 cfa05323 - Rheumatoidarthritis | |
| 473 canFam2 cfa05330 cfa05330 - Allograftrejection | |
| 474 canFam2 cfa05332 cfa05332 - Graft-versus-hostdisease | |
| 475 canFam2 cfa05340 cfa05340 - Primaryimmunodeficiency | |
| 476 canFam2 cfa05410 cfa05410 - Hypertrophiccardiomyopathy (HCM) | |
| 477 canFam2 cfa05412 cfa05412 - Arrhythmogenicright ventricular cardiomyopathy (ARVC) | |
| 478 canFam2 cfa05414 cfa05414 - Dilatedcardiomyopathy | |
| 479 canFam2 cfa05416 cfa05416 - Viralmyocarditis | |
| 480 bosTau4 bta00010 bta00010 - Glycolysis/ Gluconeogenesis | |
| 481 bosTau4 bta00020 bta00020 - Citratecycle (TCA cycle) | |
| 482 bosTau4 bta00030 bta00030 - Pentosephosphate pathway | |
| 483 bosTau4 bta00040 bta00040 - Pentoseand glucuronate interconversions | |
| 484 bosTau4 bta00051 bta00051 - Fructoseand mannose metabolism | |
| 485 bosTau4 bta00052 bta00052 - Galactosemetabolism | |
| 486 bosTau4 bta00053 bta00053 - Ascorbateand aldarate metabolism | |
| 487 bosTau4 bta00061 bta00061 - Fattyacid biosynthesis | |
| 488 bosTau4 bta00062 bta00062 - Fattyacid elongation | |
| 489 bosTau4 bta00071 bta00071 - Fattyacid metabolism | |
| 490 bosTau4 bta00072 bta00072 - Synthesisand degradation of ketone bodies | |
| 491 bosTau4 bta00100 bta00100 - Steroidbiosynthesis | |
| 492 bosTau4 bta00120 bta00120 - Primarybile acid biosynthesis | |
| 493 bosTau4 bta00130 bta00130 - Ubiquinoneand other terpenoid-quinone biosynthesis | |
| 494 bosTau4 bta00140 bta00140 - Steroidhormone biosynthesis | |
| 495 bosTau4 bta00190 bta00190 - Oxidativephosphorylation | |
| 496 bosTau4 bta00230 bta00230 - Purinemetabolism | |
| 497 bosTau4 bta00232 bta00232 - Caffeinemetabolism | |
| 498 bosTau4 bta00240 bta00240 - Pyrimidinemetabolism | |
| 499 bosTau4 bta00250 bta00250 - Alanine,aspartate and glutamate metabolism | |
| 500 bosTau4 bta00260 bta00260 - Glycine,serine and threonine metabolism | |
| 501 bosTau4 bta00270 bta00270 - Cysteineand methionine metabolism | |
| 502 bosTau4 bta00280 bta00280 - Valine,leucine and isoleucine degradation | |
| 503 bosTau4 bta00290 bta00290 - Valine,leucine and isoleucine biosynthesis | |
| 504 bosTau4 bta00300 bta00300 - Lysinebiosynthesis | |
| 505 bosTau4 bta00310 bta00310 - Lysinedegradation | |
| 506 bosTau4 bta00330 bta00330 - Arginineand proline metabolism | |
| 507 bosTau4 bta00340 bta00340 - Histidinemetabolism | |
| 508 bosTau4 bta00350 bta00350 - Tyrosinemetabolism | |
| 509 bosTau4 bta00360 bta00360 - Phenylalaninemetabolism | |
| 510 bosTau4 bta00380 bta00380 - Tryptophanmetabolism | |
| 511 bosTau4 bta00400 bta00400 - Phenylalanine,tyrosine and tryptophan biosynthesis | |
| 512 bosTau4 bta00410 bta00410 - beta-Alaninemetabolism | |
| 513 bosTau4 bta00430 bta00430 - Taurineand hypotaurine metabolism | |
| 514 bosTau4 bta00450 bta00450 - Selenocompoundmetabolism | |
| 515 bosTau4 bta00460 bta00460 - Cyanoaminoacid metabolism | |
| 516 bosTau4 bta00471 bta00471 - D-Glutamineand D-glutamate metabolism | |
| 517 bosTau4 bta00472 bta00472 - D-Arginineand D-ornithine metabolism | |
| 518 bosTau4 bta00480 bta00480 - Glutathionemetabolism | |
| 519 bosTau4 bta00500 bta00500 - Starchand sucrose metabolism | |
| 520 bosTau4 bta00510 bta00510 - N-Glycanbiosynthesis | |
| 521 bosTau4 bta00511 bta00511 - Otherglycan degradation | |
| 522 bosTau4 bta00512 bta00512 - Mucintype O-Glycan biosynthesis | |
| 523 bosTau4 bta00514 bta00514 - Othertypes of O-glycan biosynthesis | |
| 524 bosTau4 bta00520 bta00520 - Aminosugar and nucleotide sugar metabolism | |
| 525 bosTau4 bta00524 bta00524 - Butirosinand neomycin biosynthesis | |
| 526 bosTau4 bta00531 bta00531 - Glycosaminoglycandegradation | |
| 527 bosTau4 bta00532 bta00532 - Glycosaminoglycanbiosynthesis - chondroitin sulfate | |
| 528 bosTau4 bta00533 bta00533 - Glycosaminoglycanbiosynthesis - keratan sulfate | |
| 529 bosTau4 bta00534 bta00534 - Glycosaminoglycanbiosynthesis - heparan sulfate | |
| 530 bosTau4 bta00561 bta00561 - Glycerolipidmetabolism | |
| 531 bosTau4 bta00562 bta00562 - Inositolphosphate metabolism | |
| 532 bosTau4 bta00563 bta00563 - Glycosylphosphatidylinositol(GPI)-anchorbiosynthesis | |
| 533 bosTau4 bta00564 bta00564 - Glycerophospholipidmetabolism | |
| 534 bosTau4 bta00565 bta00565 - Etherlipid metabolism | |
| 535 bosTau4 bta00590 bta00590 - Arachidonicacid metabolism | |
| 536 bosTau4 bta00591 bta00591 - Linoleicacid metabolism | |
| 537 bosTau4 bta00592 bta00592 - alpha-Linolenicacid metabolism | |
| 538 bosTau4 bta00600 bta00600 - Sphingolipidmetabolism | |
| 539 bosTau4 bta00601 bta00601 - Glycosphingolipidbiosynthesis - lacto and neolacto series | |
| 540 bosTau4 bta00603 bta00603 - Glycosphingolipidbiosynthesis - globo series | |
| 541 bosTau4 bta00604 bta00604 - Glycosphingolipidbiosynthesis - ganglio series | |
| 542 bosTau4 bta00620 bta00620 - Pyruvatemetabolism | |
| 543 bosTau4 bta00630 bta00630 - Glyoxylateand dicarboxylate metabolism | |
| 544 bosTau4 bta00640 bta00640 - Propanoatemetabolism | |
| 545 bosTau4 bta00650 bta00650 - Butanoatemetabolism | |
| 546 bosTau4 bta00670 bta00670 - Onecarbon pool by folate | |
| 547 bosTau4 bta00730 bta00730 - Thiaminemetabolism | |
| 548 bosTau4 bta00740 bta00740 - Riboflavinmetabolism | |
| 549 bosTau4 bta00750 bta00750 - VitaminB6 metabolism | |
| 550 bosTau4 bta00760 bta00760 - Nicotinateand nicotinamide metabolism | |
| 551 bosTau4 bta00770 bta00770 - Pantothenateand CoA biosynthesis | |
| 552 bosTau4 bta00780 bta00780 - Biotinmetabolism | |
| 553 bosTau4 bta00785 bta00785 - Lipoicacid metabolism | |
| 554 bosTau4 bta00790 bta00790 - Folatebiosynthesis | |
| 555 bosTau4 bta00830 bta00830 - Retinolmetabolism | |
| 556 bosTau4 bta00860 bta00860 - Porphyrinand chlorophyll metabolism | |
| 557 bosTau4 bta00900 bta00900 - Terpenoidbackbone biosynthesis | |
| 558 bosTau4 bta00910 bta00910 - Nitrogenmetabolism | |
| 559 bosTau4 bta00920 bta00920 - Sulfurmetabolism | |
| 560 bosTau4 bta00970 bta00970 - Aminoacyl-tRNAbiosynthesis | |
| 561 bosTau4 bta00980 bta00980 - Metabolismof xenobiotics by cytochrome P450 | |
| 562 bosTau4 bta00982 bta00982 - Drugmetabolism - cytochrome P450 | |
| 563 bosTau4 bta00983 bta00983 - Drugmetabolism - other enzymes | |
| 564 bosTau4 bta01040 bta01040 - Biosynthesisof unsaturated fatty acids | |
| 565 bosTau4 bta01100 bta01100 - Metabolicpathways | |
| 566 bosTau4 bta02010 bta02010 - ABCtransporters | |
| 567 bosTau4 bta03008 bta03008 - Ribosomebiogenesis in eukaryotes | |
| 568 bosTau4 bta03010 bta03010 - Ribosome | |
| 569 bosTau4 bta03013 bta03013 - RNAtransport | |
| 570 bosTau4 bta03015 bta03015 - mRNAsurveillance pathway | |
| 571 bosTau4 bta03018 bta03018 - RNAdegradation | |
| 572 bosTau4 bta03020 bta03020 - RNApolymerase | |
| 573 bosTau4 bta03022 bta03022 - Basaltranscription factors | |
| 574 bosTau4 bta03030 bta03030 - DNAreplication | |
| 575 bosTau4 bta03040 bta03040 - Spliceosome | |
| 576 bosTau4 bta03050 bta03050 - Proteasome | |
| 577 bosTau4 bta03060 bta03060 - Proteinexport | |
| 578 bosTau4 bta03320 bta03320 - PPARsignaling pathway | |
| 579 bosTau4 bta03410 bta03410 - Baseexcision repair | |
| 580 bosTau4 bta03420 bta03420 - Nucleotideexcision repair | |
| 581 bosTau4 bta03430 bta03430 - Mismatchrepair | |
| 582 bosTau4 bta03440 bta03440 - Homologousrecombination | |
| 583 bosTau4 bta03450 bta03450 - Non-homologousend-joining | |
| 584 bosTau4 bta03460 bta03460 - Fanconianemia pathway | |
| 585 bosTau4 bta04010 bta04010 - MAPKsignaling pathway | |
| 586 bosTau4 bta04012 bta04012 - ErbBsignaling pathway | |
| 587 bosTau4 bta04020 bta04020 - Calciumsignaling pathway | |
| 588 bosTau4 bta04060 bta04060 - Cytokine-cytokinereceptor interaction | |
| 589 bosTau4 bta04062 bta04062 - Chemokinesignaling pathway | |
| 590 bosTau4 bta04070 bta04070 - Phosphatidylinositolsignaling system | |
| 591 bosTau4 bta04080 bta04080 - Neuroactiveligand-receptor interaction | |
| 592 bosTau4 bta04110 bta04110 - Cellcycle | |
| 593 bosTau4 bta04114 bta04114 - Oocytemeiosis | |
| 594 bosTau4 bta04115 bta04115 - p53signaling pathway | |
| 595 bosTau4 bta04120 bta04120 - Ubiquitinmediated proteolysis | |
| 596 bosTau4 bta04122 bta04122 - Sulfurrelay system | |
| 597 bosTau4 bta04130 bta04130 - SNAREinteractions in vesicular transport | |
| 598 bosTau4 bta04140 bta04140 - Regulationof autophagy | |
| 599 bosTau4 bta04141 bta04141 - Proteinprocessing in endoplasmic reticulum | |
| 600 bosTau4 bta04142 bta04142 - Lysosome | |
| 601 bosTau4 bta04144 bta04144 - Endocytosis | |
| 602 bosTau4 bta04145 bta04145 - Phagosome | |
| 603 bosTau4 bta04146 bta04146 - Peroxisome | |
| 604 bosTau4 bta04150 bta04150 - mTORsignaling pathway | |
| 605 bosTau4 bta04210 bta04210 - Apoptosis | |
| 606 bosTau4 bta04260 bta04260 - Cardiacmuscle contraction | |
| 607 bosTau4 bta04270 bta04270 - Vascularsmooth muscle contraction | |
| 608 bosTau4 bta04310 bta04310 - Wntsignaling pathway | |
| 609 bosTau4 bta04320 bta04320 - Dorso-ventralaxis formation | |
| 610 bosTau4 bta04330 bta04330 - Notchsignaling pathway | |
| 611 bosTau4 bta04340 bta04340 - Hedgehogsignaling pathway | |
| 612 bosTau4 bta04350 bta04350 - TGF-betasignaling pathway | |
| 613 bosTau4 bta04360 bta04360 - Axonguidance | |
| 614 bosTau4 bta04370 bta04370 - VEGFsignaling pathway | |
| 615 bosTau4 bta04380 bta04380 - Osteoclastdifferentiation | |
| 616 bosTau4 bta04510 bta04510 - Focaladhesion | |
| 617 bosTau4 bta04512 bta04512 - ECM-receptorinteraction | |
| 618 bosTau4 bta04514 bta04514 - Celladhesion molecules (CAMs) | |
| 619 bosTau4 bta04520 bta04520 - Adherensjunction | |
| 620 bosTau4 bta04530 bta04530 - Tightjunction | |
| 621 bosTau4 bta04540 bta04540 - Gapjunction | |
| 622 bosTau4 bta04610 bta04610 - Complementand coagulation cascades | |
| 623 bosTau4 bta04612 bta04612 - Antigenprocessing and presentation | |
| 624 bosTau4 bta04614 bta04614 - Renin-angiotensinsystem | |
| 625 bosTau4 bta04620 bta04620 - Toll-likereceptor signaling pathway | |
| 626 bosTau4 bta04621 bta04621 - NOD-likereceptor signaling pathway | |
| 627 bosTau4 bta04622 bta04622 - RIG-I-likereceptor signaling pathway | |
| 628 bosTau4 bta04623 bta04623 - CytosolicDNA-sensing pathway | |
| 629 bosTau4 bta04630 bta04630 - Jak-STATsignaling pathway | |
| 630 bosTau4 bta04640 bta04640 - Hematopoieticcell lineage | |
| 631 bosTau4 bta04650 bta04650 - Naturalkiller cell mediated cytotoxicity | |
| 632 bosTau4 bta04660 bta04660 - Tcell receptor signaling pathway | |
| 633 bosTau4 bta04662 bta04662 - Bcell receptor signaling pathway | |
| 634 bosTau4 bta04664 bta04664 - Fcepsilon RI signaling pathway | |
| 635 bosTau4 bta04666 bta04666 - Fcgamma R-mediated phagocytosis | |
| 636 bosTau4 bta04670 bta04670 - Leukocytetransendothelial migration | |
| 637 bosTau4 bta04672 bta04672 - Intestinalimmune network for IgA production | |
| 638 bosTau4 bta04710 bta04710 - Circadianrhythm - mammal | |
| 639 bosTau4 bta04720 bta04720 - Long-termpotentiation | |
| 640 bosTau4 bta04721 bta04721 - Synapticvesicle cycle | |
| 641 bosTau4 bta04722 bta04722 - Neurotrophinsignaling pathway | |
| 642 bosTau4 bta04724 bta04724 - Glutamatergicsynapse | |
| 643 bosTau4 bta04725 bta04725 - Cholinergicsynapse | |
| 644 bosTau4 bta04727 bta04727 - GABAergicsynapse | |
| 645 bosTau4 bta04728 bta04728 - Dopaminergicsynapse | |
| 646 bosTau4 bta04730 bta04730 - Long-termdepression | |
| 647 bosTau4 bta04740 bta04740 - Olfactorytransduction | |
| 648 bosTau4 bta04742 bta04742 - Tastetransduction | |
| 649 bosTau4 bta04744 bta04744 - Phototransduction | |
| 650 bosTau4 bta04810 bta04810 - Regulationof actin cytoskeleton | |
| 651 bosTau4 bta04910 bta04910 - Insulinsignaling pathway | |
| 652 bosTau4 bta04912 bta04912 - GnRHsignaling pathway | |
| 653 bosTau4 bta04914 bta04914 - Progesterone-mediatedoocyte maturation | |
| 654 bosTau4 bta04916 bta04916 - Melanogenesis | |
| 655 bosTau4 bta04920 bta04920 - Adipocytokinesignaling pathway | |
| 656 bosTau4 bta04930 bta04930 - TypeII diabetes mellitus | |
| 657 bosTau4 bta04940 bta04940 - TypeI diabetes mellitus | |
| 658 bosTau4 bta04950 bta04950 - Maturityonset diabetes of the young | |
| 659 bosTau4 bta04960 bta04960 - Aldosterone-regulatedsodium reabsorption | |
| 660 bosTau4 bta04961 bta04961 - Endocrineand other factor-regulated calcium reabsorption | |
| 661 bosTau4 bta04962 bta04962 - Vasopressin-regulatedwater reabsorption | |
| 662 bosTau4 bta04964 bta04964 - Proximaltubule bicarbonate reclamation | |
| 663 bosTau4 bta04966 bta04966 - Collectingduct acid secretion | |
| 664 bosTau4 bta04970 bta04970 - Salivarysecretion | |
| 665 bosTau4 bta04971 bta04971 - Gastricacid secretion | |
| 666 bosTau4 bta04972 bta04972 - Pancreaticsecretion | |
| 667 bosTau4 bta04973 bta04973 - Carbohydratedigestion and absorption | |
| 668 bosTau4 bta04974 bta04974 - Proteindigestion and absorption | |
| 669 bosTau4 bta04975 bta04975 - Fatdigestion and absorption | |
| 670 bosTau4 bta04976 bta04976 - Bilesecretion | |
| 671 bosTau4 bta04977 bta04977 - Vitamindigestion and absorption | |
| 672 bosTau4 bta04978 bta04978 - Mineralabsorption | |
| 673 bosTau4 bta05010 bta05010 - Alzheimer'sdisease | |
| 674 bosTau4 bta05012 bta05012 - Parkinson'sdisease | |
| 675 bosTau4 bta05014 bta05014 - Amyotrophiclateral sclerosis (ALS) | |
| 676 bosTau4 bta05016 bta05016 - Huntington'sdisease | |
| 677 bosTau4 bta05020 bta05020 - Priondiseases | |
| 678 bosTau4 bta05100 bta05100 - Bacterialinvasion of epithelial cells | |
| 679 bosTau4 bta05132 bta05132 - Salmonellainfection | |
| 680 bosTau4 bta05133 bta05133 - Pertussis | |
| 681 bosTau4 bta05134 bta05134 - Legionellosis | |
| 682 bosTau4 bta05140 bta05140 - Leishmaniasis | |
| 683 bosTau4 bta05142 bta05142 - Chagasdisease (American trypanosomiasis) | |
| 684 bosTau4 bta05143 bta05143 - Africantrypanosomiasis | |
| 685 bosTau4 bta05144 bta05144 - Malaria | |
| 686 bosTau4 bta05145 bta05145 - Toxoplasmosis | |
| 687 bosTau4 bta05146 bta05146 - Amoebiasis | |
| 688 bosTau4 bta05150 bta05150 - Staphylococcusaureus infection | |
| 689 bosTau4 bta05152 bta05152 - Tuberculosis | |
| 690 bosTau4 bta05160 bta05160 - HepatitisC | |
| 691 bosTau4 bta05162 bta05162 - Measles | |
| 692 bosTau4 bta05164 bta05164 - InfluenzaA | |
| 693 bosTau4 bta05166 bta05166 - HTLV-Iinfection | |
| 694 bosTau4 bta05168 bta05168 - Herpessimplex infection | |
| 695 bosTau4 bta05200 bta05200 - Pathwaysin cancer | |
| 696 bosTau4 bta05202 bta05202 - Transcriptionalmisregulation in cancers | |
| 697 bosTau4 bta05210 bta05210 - Colorectalcancer | |
| 698 bosTau4 bta05211 bta05211 - Renalcell carcinoma | |
| 699 bosTau4 bta05212 bta05212 - Pancreaticcancer | |
| 700 bosTau4 bta05213 bta05213 - Endometrialcancer | |
| 701 bosTau4 bta05214 bta05214 - Glioma | |
| 702 bosTau4 bta05215 bta05215 - Prostatecancer | |
| 703 bosTau4 bta05216 bta05216 - Thyroidcancer | |
| 704 bosTau4 bta05217 bta05217 - Basalcell carcinoma | |
| 705 bosTau4 bta05218 bta05218 - Melanoma | |
| 706 bosTau4 bta05219 bta05219 - Bladdercancer | |
| 707 bosTau4 bta05220 bta05220 - Chronicmyeloid leukemia | |
| 708 bosTau4 bta05221 bta05221 - Acutemyeloid leukemia | |
| 709 bosTau4 bta05222 bta05222 - Smallcell lung cancer | |
| 710 bosTau4 bta05223 bta05223 - Non-smallcell lung cancer | |
| 711 bosTau4 bta05310 bta05310 - Asthma | |
| 712 bosTau4 bta05320 bta05320 - Autoimmunethyroid disease | |
| 713 bosTau4 bta05322 bta05322 - Systemiclupus erythematosus | |
| 714 bosTau4 bta05323 bta05323 - Rheumatoidarthritis | |
| 715 bosTau4 bta05330 bta05330 - Allograftrejection | |
| 716 bosTau4 bta05332 bta05332 - Graft-versus-hostdisease | |
| 717 bosTau4 bta05340 bta05340 - Primaryimmunodeficiency | |
| 718 bosTau4 bta05410 bta05410 - Hypertrophiccardiomyopathy (HCM) | |
| 719 bosTau4 bta05412 bta05412 - Arrhythmogenicright ventricular cardiomyopathy (ARVC) | |
| 720 bosTau4 bta05414 bta05414 - Dilatedcardiomyopathy | |
| 721 bosTau4 bta05416 bta05416 - Viralmyocarditis |